弥漫增生性肾母细胞瘤病1例

2020-06-16 王希恒 康冰 孙丛 医学影像学杂志

患儿男,11个月17天。因发现腹部无痛性肿物1周入院,无发热、血尿等不适。体格检查:一般情况良好,生长发育正常,腹部膨隆。无类似家族遗传病史。腹部CT示:双肾体积明显增大,大小分别约12.6 cm&t

患儿男,11个月17天。因发现腹部无痛性肿物1周入院,无发热、血尿等不适。体格检查:一般情况良好,生长发育正常,腹部膨隆。无类似家族遗传病史。腹部CT示:双肾体积明显增大,大小分别约12.6 cm×10.8 cm×6.9 cm(左)、12.1 cm×8.5 cm×7.4 cm(右),轮廓大致正常,内可见多发弥漫性大小不等的软组织结节及肿块影,边界不清,增强扫描部分病变呈不均质强化,强化程度明显弱于肾实质,结节及肿块之间及周边可见残存的正常强化肾实质,残存的正常肾实质明显受压变薄,肾集合系统受压变形,局部可见轻度扩张,其内未见充盈缺损征象。腹腔和腹膜后未见肿大淋巴结(图1,2)。


图1,2强化CT示双肾弥漫大小不等结节或肿块影,双肾轮廓大致正常,部分可见不均质强化(白箭),右肾集合系统受压、积水。(图1为横轴位,图2为冠状位)。

右肾穿刺病理:弥漫增生性肾母细胞瘤病,肿瘤细胞大小较一致,大部分呈菊形团样或小管状排列,部分区域间质丰富,由疏松的梭形细胞构成,未见成熟的肾小管及肾小球结构(图3,4)。


图3,4右肾病理图像示肿瘤细胞大小较一致,大部分呈菊形团样或小管状排列,部分区域间质丰富,由疏松的梭形细胞构成,未见成熟的肾小管及肾小球结构

讨论

肾母细胞瘤病(nephroblastomatosis,NS)临床少见,属于良性病变,但存在恶变为肾母细胞瘤(又称Wilms tumor,WT)的潜能。弥漫增生性肾母细胞瘤病(diffuse hyperplastic nephroblastomatosis,DHNS)是指单肾或双肾实质全部或部分被肾源性组织填充。

病理学:肾源性残余(nephrogenic rests,NR)是指肾内异常残存的肾胚芽细胞,代表肾发育过程的异型增殖细胞。NS是指多灶、弥漫分布的NR,分为叶周型、叶内型、混合型及全小叶型四种类型。NR和NS都被称为WT的前驱病变,两者恶变率分别约25%~40%和46%。据报道,叶周型NS恶变率较高,尤其是弥漫增生性叶周型NS。临床表现:NS可在任何年龄发生,但在婴儿中最常见,一般以腹部膨隆及无痛性包块就诊,通常为多发,约40%的病例为双侧,而WT双侧发病率约为6%~7%,单侧多发发病率约为7%。值得注意的是,当一侧肾存在NS时,对侧肾一般合并镜下NR,其WT的发病风险会明显增高。

影像学表现:在超声上,NS表现为肾体积增大,与肾皮质相比,病灶为均匀等回声或低回声。Perlman EJ等报道52例叶周型NS,在CT上,其表现为肾体积增大,但肾轮廓保持不变,病变为多发、密度较为均质的结节,常位于肾实质近皮质区,较小的病灶平扫容易遗漏。在MRI上,与肾皮质相比,病变T1WI呈等或略低信号,T2WI呈等、低或高信号,增强扫描多无强化或轻度强化,程度明显低于肾实质。

鉴别诊断:由于NS与WT生物学行为的不同,其临床治疗方案迥异,故两者的诊断及鉴别诊断,以及确定NS是否合并WT均十分重要。临床工作中,主要依据其影像学和病理学特点进行鉴别。通常,NS肾轮廓保持不变,呈多发结节状,质地较均质,无假包膜,增强扫描多轻度均质强化;而后者一般体积较大,呈肿块状,膨胀性、外生性生长,且存在假包膜,增强扫描呈明显不均质强化,见表1。

表1 NR、NS及WT临床及主要影像表现


本例的影像学特点主要表现为双肾轮廓大致正常,内见弥漫大小不等的结节及肿块,大部分结节呈均质轻度强化,部分病变内见不均质强化。穿刺病理显示为DHNS。值得注意的是,病理学检查是诊断金标准,但其所取样组织的部位及数量制约较大,仅凭局部标本对于该病的诊断价值有限,常会导致WT的假阴性诊断,因此,直观而全面的影像学检查及影像导引下的活检必不可少,对于病变体积较大,且质地欠均质的部分,应高度警惕转化或合并WT的可能性,应予以关注和活检取样。

NS除了与NR及WT鉴别外,还需要与先天性中胚层肾瘤(congenital mesoblastic nephroma,CMN)、肾透明细胞肉瘤(clear cell sarcoma of the renal,CCSR)和肾横纹肌样瘤(rhabdoid tumours of the renal,RTR)等疾病鉴别。CMN主要发生在小于3个月的新生儿,而NS中位年龄约16个月;CCSR为富血供肿瘤,坏死和出血常见,增强扫描呈“虎斑征”且易出现骨转移,而NS多表现为质地均质,且增强扫描强化不明显;RTR表现为不均质的肿块,边缘可见细线状钙化,肾周筋膜呈结节状增厚,肾被膜下可见新月形积液。

治疗:NS的主要治疗方案为化疗,化疗可以使NS数量可减少,体积变小,也可以延缓NS向WT的转化。在PerlmanEJ等的研究中,经化疗的患儿从NS初诊到出现WT的平均时间为35个月,而未接受化疗的患儿约为6.5个月。如果患者在NS化疗期间出现WT,也可行保留肾单位的手术。

总之,NS在影像学表现上具有一定的特点,能够进行诊断及鉴别诊断,对治疗方案的制定具有重要价值,其最终确诊仍需结合病理学检查。

原始出处:

王希恒,康冰,孙丛.弥漫增生性肾母细胞瘤病1例[J].医学影像学杂志,2019,29(03):518-520.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1757331, encodeId=ecf21e5733118, content=<a href='/topic/show?id=2f354231613' target=_blank style='color:#2F92EE;'>#增生性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42316, encryptionId=2f354231613, topicName=增生性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f7c37300907, createdName=ms7514935887898259, createdTime=Tue Aug 25 13:00:09 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772351, encodeId=dc121e7235152, content=<a href='/topic/show?id=c38963544cc' target=_blank style='color:#2F92EE;'>#母细胞瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63544, encryptionId=c38963544cc, topicName=母细胞瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b07438375157, createdName=huperzia, createdTime=Tue Aug 18 07:00:09 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476076, encodeId=6b2414e607660, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77977, encryptionId=2bcee797732, topicName=细胞瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf5e7252474, createdName=spoonycyy, createdTime=Thu Jun 18 04:00:09 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534985, encodeId=76a61534985ee, content=<a href='/topic/show?id=caac8256402' target=_blank style='color:#2F92EE;'>#肾母细胞瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82564, encryptionId=caac8256402, topicName=肾母细胞瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d1b12575689, createdName=yulin2010, createdTime=Thu Jun 18 04:00:09 CST 2020, time=2020-06-18, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1757331, encodeId=ecf21e5733118, content=<a href='/topic/show?id=2f354231613' target=_blank style='color:#2F92EE;'>#增生性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42316, encryptionId=2f354231613, topicName=增生性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f7c37300907, createdName=ms7514935887898259, createdTime=Tue Aug 25 13:00:09 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772351, encodeId=dc121e7235152, content=<a href='/topic/show?id=c38963544cc' target=_blank style='color:#2F92EE;'>#母细胞瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63544, encryptionId=c38963544cc, topicName=母细胞瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b07438375157, createdName=huperzia, createdTime=Tue Aug 18 07:00:09 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476076, encodeId=6b2414e607660, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77977, encryptionId=2bcee797732, topicName=细胞瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf5e7252474, createdName=spoonycyy, createdTime=Thu Jun 18 04:00:09 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534985, encodeId=76a61534985ee, content=<a href='/topic/show?id=caac8256402' target=_blank style='color:#2F92EE;'>#肾母细胞瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82564, encryptionId=caac8256402, topicName=肾母细胞瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d1b12575689, createdName=yulin2010, createdTime=Thu Jun 18 04:00:09 CST 2020, time=2020-06-18, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1757331, encodeId=ecf21e5733118, content=<a href='/topic/show?id=2f354231613' target=_blank style='color:#2F92EE;'>#增生性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42316, encryptionId=2f354231613, topicName=增生性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f7c37300907, createdName=ms7514935887898259, createdTime=Tue Aug 25 13:00:09 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772351, encodeId=dc121e7235152, content=<a href='/topic/show?id=c38963544cc' target=_blank style='color:#2F92EE;'>#母细胞瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63544, encryptionId=c38963544cc, topicName=母细胞瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b07438375157, createdName=huperzia, createdTime=Tue Aug 18 07:00:09 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476076, encodeId=6b2414e607660, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77977, encryptionId=2bcee797732, topicName=细胞瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf5e7252474, createdName=spoonycyy, createdTime=Thu Jun 18 04:00:09 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534985, encodeId=76a61534985ee, content=<a href='/topic/show?id=caac8256402' target=_blank style='color:#2F92EE;'>#肾母细胞瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82564, encryptionId=caac8256402, topicName=肾母细胞瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d1b12575689, createdName=yulin2010, createdTime=Thu Jun 18 04:00:09 CST 2020, time=2020-06-18, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1757331, encodeId=ecf21e5733118, content=<a href='/topic/show?id=2f354231613' target=_blank style='color:#2F92EE;'>#增生性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42316, encryptionId=2f354231613, topicName=增生性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f7c37300907, createdName=ms7514935887898259, createdTime=Tue Aug 25 13:00:09 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772351, encodeId=dc121e7235152, content=<a href='/topic/show?id=c38963544cc' target=_blank style='color:#2F92EE;'>#母细胞瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63544, encryptionId=c38963544cc, topicName=母细胞瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b07438375157, createdName=huperzia, createdTime=Tue Aug 18 07:00:09 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476076, encodeId=6b2414e607660, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77977, encryptionId=2bcee797732, topicName=细胞瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf5e7252474, createdName=spoonycyy, createdTime=Thu Jun 18 04:00:09 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534985, encodeId=76a61534985ee, content=<a href='/topic/show?id=caac8256402' target=_blank style='color:#2F92EE;'>#肾母细胞瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82564, encryptionId=caac8256402, topicName=肾母细胞瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d1b12575689, createdName=yulin2010, createdTime=Thu Jun 18 04:00:09 CST 2020, time=2020-06-18, status=1, ipAttribution=)]